Department of Community Medicine, West Virginia University School of Medicine, P.O. Box 9190, Morgantown, WV 26506-9190, USA.
Sleep Med. 2011 Aug;12(7):623-34. doi: 10.1016/j.sleep.2010.12.018. Epub 2011 Jul 12.
Restless legs syndrome (RLS) is a potentially debilitating sleep disorder that affects a significant percentage of North American and European adults. Although standardized RLS diagnostic criteria are now established and widely accepted, reported prevalence estimates have varied widely. In this paper, we review the literature regarding RLS prevalence in North American and Western European adult populations, examine potential sources of variation, briefly discuss the impact of RLS, and offer recommendations for future research.
To identify qualifying studies, we searched 6 scientific databases and scanned bibliographies of relevant review papers and all identified articles. Studies including fewer than 300 participants, that did not use any of the 4 standard diagnostic criteria, were published prior to 1995 or targeted clinical populations were excluded.
Thirty-four papers detailing results of large, population-based studies in 16 North American and Western European countries met our inclusion criteria, including 5 multi-country studies (N=69,992 participants) and 29 single country studies (N=163,188 participants); all but one were cross-sectional. Reported general prevalence rates ranged from 4% to 29% of adults, averaging 14.5±8.0% across studies. Reported prevalence averaged higher in primary care populations than in populations derived from random sampling or geographically defined cohorts (19.5±7.9% vs. 12.3±7.2%). Diagnostic and severity criteria differed considerably among studies, as did inclusion criteria, with corresponding variation in prevalence estimates. Prevalence averaged higher in women and older adults; more limited data suggest race/ethnicity, parity, health status, and other factors may also contribute to the observed variation in prevalence. RLS has profound, negative effects on health, well-being, and quality of life, yet detection rates remain low.
Collectively, these studies indicate that RLS is a common disorder of major clinical and public health significance in the Western industrialized world, affecting between 4% and 29% of adults. The wide variation in reported prevalence likely reflects differences in demographic factors, health status, and other population characteristics; study population source and sampling frame; and inconsistencies in RLS diagnostic criteria and procedures. Prospective studies and corresponding incidence data on RLS are lacking, hindering the evaluation of both causal factors and sequelae.
不宁腿综合征(RLS)是一种潜在的使人虚弱的睡眠障碍,影响了相当大比例的北美和欧洲成年人。尽管现在已经确立并广泛接受了标准化的 RLS 诊断标准,但报告的患病率估计值差异很大。在本文中,我们回顾了北美和西欧成年人群体中 RLS 患病率的文献,检查了潜在的变异来源,简要讨论了 RLS 的影响,并为未来的研究提供了建议。
为了确定合格的研究,我们搜索了 6 个科学数据库,并对相关综述论文和所有已确定的文章的参考文献进行了扫描。排除了参与者少于 300 人的研究、未使用任何 4 项标准诊断标准的研究、发表于 1995 年之前的研究以及针对临床人群的研究。
34 篇详细描述了 16 个北美和西欧国家大型人群研究结果的论文符合我们的纳入标准,包括 5 项多国研究(N=69992 名参与者)和 29 项单国研究(N=163188 名参与者);除了一项研究外,其余都是横断面研究。报告的成人一般患病率从 4%到 29%不等,平均为研究中的 14.5±8.0%。在初级保健人群中报告的患病率平均高于随机抽样或地理定义队列人群(19.5±7.9%比 12.3±7.2%)。研究之间的诊断和严重程度标准差异很大,纳入标准也不同,相应的患病率估计值也存在差异。患病率在女性和老年人中平均较高;更有限的数据表明,种族/民族、生育状况、健康状况和其他因素也可能导致患病率的变化。RLS 对健康、幸福和生活质量有深远的负面影响,但检出率仍然很低。
总的来说,这些研究表明,RLS 是西方工业化世界一种常见的具有重要临床和公共卫生意义的疾病,影响了 4%至 29%的成年人。报告的患病率差异很大,可能反映了人口统计学因素、健康状况和其他人口特征的差异;研究人群来源和抽样框架;以及 RLS 诊断标准和程序的不一致性。缺乏关于 RLS 的前瞻性研究和相应的发病率数据,这阻碍了对因果因素和后果的评估。